Breaking News

BioMed X and Janssen R&D announce two research groups

The groups will explore research related to autoimmunity and drug delivery

Eisai and Biogen announce Phase IV Alzheimer's study design

The companies will be evaluating the long-term effectiveness and safety data of Biogen's Alzheimer's therapy, Aduhelm

Touchlight and Vanderbilt University collaborate on pandemic response

The collaboration will explore the use of synthetic dbDNA to deliver antibody-based prophylaxis against pandemic ...

The supply chain forum: four pillars of capsule-based dry powder inhaler (cDPI) optimisation (part I)

Affordable and patient-centric, capsule-based dry powder inhaler (cDPI) combinations are providing the flexibility ...

CN Bio licenses gut modelling tool from MIT

The GuMi device was licensed by Professor Linda Griffith at MIT's Department of Biological Engineering and joint patent- ...

Nanopharm and Leyden Labs to develop nasal sprays for virus protection

Leyden Labs’ platform targets commonalities of viral families to develop candidates that protect against many strains ...

Manufacturing vaccines, digital twins and lessons learned: part I

Using a digital replica of the manufacturing process, the pharmaceutical industry is exploring the ability of virtual ...

Stablepharma partners with University of Strathclyde on StablevaX tech

The WHO estimates that up to 50% of all vaccines manufactured currently lose their efficacy before they can be delivered

Aptamer partners with pharma company on vaccine development

The global pharmaceutical company will use Aptamer’s Optimer reagents to support the development of a vaccine ...

Manufacturing vaccines, digital twins and lessons learned: part II

Using a digital replica of the manufacturing process, the pharmaceutical industry is exploring the ability of virtual ...

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Developing drugs using a lab in the cloud

Emerald Cloud Lab’s Toby Blackburn explains the benefits of uploading an entire R&D facility to the cloud

BioMed X and Merck launch oncology research programme

The key aim of the project will be to generate a comprehensive atlas of extrachromosomal DNA in human cancer tissues

Protagen Protein Services merges with GeneWerk

The move establishes a premier, protein and gene analytic testing service platform worldwide